mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2022-4-7-14mrj-1316Research ArticleЛЕКЦИЯLECTUREПоражение кожи при системной красной волчанке. Часть 2: клинические и гистологические особенностиSkin lesions in systemic lupus erythematosus. Part 2: clinical and histological featureshttps://orcid.org/0000-0003-1318-1894ШумиловаА. А.ShumilovaA. A.

 Анастасия Александровна Шумилова 

Россия, 115522, Москва, Каширское шоссе, 34А 

 Anastasia Aleksandrovna Shumilova 

34A, Kashirskoe shosse, Moscow 115522, Russia 

dr.anashumilova@gmail.comhttps://orcid.org/0000-0002-6399-8766ТравкинаЕ. И.TravkinaE. I.

 Россия, 115522, Москва, Каширское шоссе, 34А 

 34A, Kashirskoe shosse, Moscow 115522, Russia 

https://orcid.org/0000-0003-3552-2522РешетнякТ. М.ReshetnyakT. M.

 Россия, 115522, Москва, Каширское шоссе, 34А 

 Россия, 125993, Москва, ул. Баррикадная, 2/1, стр. 1 

 34A, Kashirskoe shosse, Moscow 115522, Russia 

 2/1, Barrikadnaya street, building 1, Moscow 125993, Russia 

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; кафедра ревматологии ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияV.A. Nasonova Research Institute of Rheumatology; Department of Rheumatology, Russian Medical Academy of Continuing Professional EducationRussian Federation202219082022164714Copyright © Шумилова А.А., Травкина Е.И., Решетняк Т.М., 20222022Шумилова А.А., Травкина Е.И., Решетняк Т.М.Shumilova A.A., Travkina E.I., Reshetnyak T.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/1316

Поражение кожи при системной красной волчанке (СКВ) – не просто косметический дефект, сопровождающийся ухудшением качества жизни и психологическим дискомфортом, а, возможно, первый признак системного поражения при данном заболевании. Системное поражение может развиться у пациентов практически с любым типом красной кожной волчанки (ККВ), что требует изучения ККВ в сочетании с СКВ. В первую очередь с кожными проявлениями СКВ встречаются дерматологи, тогда как поражение других органов и систем приводит пациента к ревматологу. Важно понимать, что поражение кожи не вызывает необратимых органных повреждений, однако необходима преемственность терапевтических подходов между дерматологом и ревматологом. В обзоре приведены клинические признаки, особенности диагностики и гистологические характеристики ККВ.

Skin lesions in systemic lupus erythematosus (SLE) are not just a cosmetic defect, accompanied by a deterioration in the quality of life and psychological discomfort, but, possibly, the first sign of a systemic course of disease. Systemic involvement can develop in patients with almost any type of cutaneous lupus erythematosus (CLE), requiring the study of CLE in combination with SLE. Dermatologists are the first to face with skin manifestations of SLE, while other organs and systems affection leads the patient to a rheumatologist. It is important to understand that skin lesions do not cause irreversible organ damage, but continuity of therapeutic approaches between a dermatologist and a rheumatologist is necessary. The review presents the clinical signs, diagnostic features and histological characteristics of CLE.

системная красная волчанкакожная красная волчанкапоражение кожипоражение слизистых оболочекострая кожная красная волчанкаподострая кожная красная волчанкадискоидная красная волчанкаволчаночный панникулитволчанка обмороженияопухолевидная красная волчанкаперекрестный синдромsystemic lupus erythematosuscutaneous lupus erythematosusskin lesionsmucous membranes affectionacute cutaneous lupus erythematosussubacute cutaneous lupus erythematosusdiscoid lupus erythematosuslupus panniculitischilblain lupuslupus erythematosus tumidoscross syndromeРабота выполнена в рамках фундаментальной темы FURS-2022-003.The investigation has been conducted within fundamental research topic FURS-2022-003.ReferencesРешетняк ТМ. Системная красная волчанка. В Кн. Бадокин ВВ, редактор. Ревматология. Клинические лекции. Москва: Литтера; 2012. С. 245-331.Reshetnyak TM. Systemic lupus erythematosus. In: Badokin VV, editor. Revmatologiya. Klinicheskie lektsii [Rheumatology. Clinical lectures]. Moscow: Litera; 2012. P. 245-331.Иванова ММ. Системная красная волчанка. В кн. Сигидин ЯА, Гусева НГ, Иванова ММ, редакторы. Диффузные болезни соединительной ткани. Руководство для врачей. Москва: Медицина; 2004. С. 253-341.Ivanovа MM. Systemic lupus erythematosus. In: Sigidin YaA, Guseva NG, Ivanova MM, editors. Diffuznye bolezni soedinitel'noi tkani. Rukovodstvo dlya vrachei. [Diffuse connective tissue diseases. A guide for doctors]. Moscow: Meditsina; 2004. P. 253-341.Wahie S, McColl E, Reynolds N, Meggitt S. Measuring disease activity and damage in discoid lupus erythematosus. Br J Dermatol. 2010 May;162(5):1030-7. doi: 10.1111/j.1365-2133.2010.09656.x.Epub 2010 Mar 1.Wahie S, McColl E, Reynolds N, Meggitt S. Measuring disease activity and damage in discoid lupus erythematosus. Br J Dermatol. 2010 May;162(5):1030-7. doi: 10.1111/j.1365-2133.2010.09656.x.Epub 2010 Mar 1.Gronhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011 Jun; 164(6):1335-41. doi: 10.1111/j.1365-2133.2011.10272.x. Epub 2011 May 17.Gronhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011 Jun; 164(6):1335-41. doi: 10.1111/j.1365-2133.2011.10272.x. Epub 2011 May 17.Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. Sep-Oct 2006; 24(5):348-62. doi: 10.1016/j.clindermatol.2006.07.014.Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. Sep-Oct 2006; 24(5):348-62. doi: 10.1016/j.clindermatol.2006.07.014.Veraldi S, Persico MC, Francia C. Morbihan syndrome. Indian Dermatol Online J. 2013 Apr-Jun; 4(2): 122-4. doi: 10.4103/2229-5178.110639.Veraldi S, Persico MC, Francia C. Morbihan syndrome. Indian Dermatol Online J. 2013 Apr-Jun; 4(2): 122-4. doi: 10.4103/2229-5178.110639.Donthi D, Nenow J, Samia A, et al. Morbihan disease: A diagnostic dilemma: two cases with successful resolution. SAGE Open Med Case Rep. 2021 Jun 11;9:2050313X211023655. doi: 10.1177/2050313X211023655.Donthi D, Nenow J, Samia A, et al. Morbihan disease: A diagnostic dilemma: two cases with successful resolution. SAGE Open Med Case Rep. 2021 Jun 11;9:2050313X211023655. doi: 10.1177/2050313X211023655.Lee LA, Roberts CM, Frank MB, et al. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol. 1994 Oct;130(10):1262-8.Lee LA, Roberts CM, Frank MB, et al. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol. 1994 Oct;130(10):1262-8.Shumilova AA, Cheldieva FA, Reshetnyak TM, Lila AM. Skin lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2021 Jun; 80(Suppl 1):643.2-644. doi: 10.1136/annrheumdis-2021-eular.3548.Shumilova AA, Cheldieva FA, Reshetnyak TM, Lila AM. Skin lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2021 Jun; 80(Suppl 1):643.2-644. doi: 10.1136/annrheumdis-2021-eular.3548.Filotico R, Mastrandrea V. Cutaneous lupus erythematosus: clinico-pathologic correlation. G Ital Dermatol Venereol. 2018 Apr; 153(2):216-29. doi: 10.23736/S0392-0488.18.05929-1.Filotico R, Mastrandrea V. Cutaneous lupus erythematosus: clinico-pathologic correlation. G Ital Dermatol Venereol. 2018 Apr; 153(2):216-29. doi: 10.23736/S0392-0488.18.05929-1.Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979 Dec; 115(12):1409-15.Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979 Dec; 115(12):1409-15.Sontheimer RD. Subacute cutaneous lupus erythematosus. Clin Dermatol. 1985 Jul-Sep;3(3):58-68. doi: 10.1016/0738-081x(85)90078-1.Sontheimer RD. Subacute cutaneous lupus erythematosus. Clin Dermatol. 1985 Jul-Sep;3(3):58-68. doi: 10.1016/0738-081x(85)90078-1.Lowe GC, Henderson CL, Grau RH, et al. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011 Mar;164(3):465-72. doi: 10.1111/j.1365-2133.2010.10110.x.Lowe GC, Henderson CL, Grau RH, et al. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011 Mar;164(3):465-72. doi: 10.1111/j.1365-2133.2010.10110.x.Sonntag M, Lehmann P, Megahed M, et al. Papulonodular mucinosis associated with subacute cutaneous lupus erythematosus. Dermatology. 2003;206(4):326-9. doi: 10.1159/000069945.Sonntag M, Lehmann P, Megahed M, et al. Papulonodular mucinosis associated with subacute cutaneous lupus erythematosus. Dermatology. 2003;206(4):326-9. doi: 10.1159/000069945.Rongioletti F, Parodi A, Rebora A. Papular and nodular mucinosis as a sign of lupus erythematosus. Dermatologica. 1990; 180(4):221-3. doi: 10.1159/000248034.Rongioletti F, Parodi A, Rebora A. Papular and nodular mucinosis as a sign of lupus erythematosus. Dermatologica. 1990; 180(4):221-3. doi: 10.1159/000248034.Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol. 1984 Mar;120(3):332-7.Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol. 1984 Mar;120(3):332-7.David-Bajar KM, Bennion SD, DeSpain JD, et al. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol. 1992 Sep;99(3):251-7. doi: 10.1111/1523-1747.ep12616582.David-Bajar KM, Bennion SD, DeSpain JD, et al. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol. 1992 Sep;99(3):251-7. doi: 10.1111/1523-1747.ep12616582.Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun. Feb-Mar 2014;48-9: 14-9. doi: 10.1016/j.jaut.2014.01.021. Epub 2014 Jan 31.Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun. Feb-Mar 2014;48-9: 14-9. doi: 10.1016/j.jaut.2014.01.021. Epub 2014 Jan 31.Moura Filho JP, Peixoto RL, Martins LG, et al. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects. An Bras Dermatol. Jan-Feb 2014; 89(1):118-25. doi: 10.1590/abd1806-4841.20142146.Moura Filho JP, Peixoto RL, Martins LG, et al. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects. An Bras Dermatol. Jan-Feb 2014; 89(1):118-25. doi: 10.1590/abd1806-4841.20142146.Cardinali C, Caproni M, Bernacchi E, et al. The spectrum of cutaneous manifestations in lupus erythematosus-the Italian experience. Lupus. 2000;9(6):417-23. doi: 10.1191/096120300678828569.Cardinali C, Caproni M, Bernacchi E, et al. The spectrum of cutaneous manifestations in lupus erythematosus-the Italian experience. Lupus. 2000;9(6):417-23. doi: 10.1191/096120300678828569.Grönhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011 Jun; 164(6):1335-41. doi: 10.1111/j.1365-2133.2011.10272.x.Grönhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011 Jun; 164(6):1335-41. doi: 10.1111/j.1365-2133.2011.10272.x.Albrecht J, Berlin JA, Braverman IM, et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus. 2004;13(11): 839-49. doi: 10.1191/0961203304lu2020oa.Albrecht J, Berlin JA, Braverman IM, et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus. 2004;13(11): 839-49. doi: 10.1191/0961203304lu2020oa.Al-Refu K, Goodfield M. Hair follicle stem cells in the pathogenesis of the scarring process in cutaneous lupus erythematosus. Autoimmun Rev. 2009 May;8(6):474-7. doi: 10.1016/j.autrev.2008.12.015.Al-Refu K, Goodfield M. Hair follicle stem cells in the pathogenesis of the scarring process in cutaneous lupus erythematosus. Autoimmun Rev. 2009 May;8(6):474-7. doi: 10.1016/j.autrev.2008.12.015.Choi MY, Flood K, Bernatsky S, et al. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017 Jun;31(3):373-96. doi: 10.1016/j.berh.2017.09.013.Choi MY, Flood K, Bernatsky S, et al. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017 Jun;31(3):373-96. doi: 10.1016/j.berh.2017.09.013.Elman SA, Joyce C, Nyberg F, et al. Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise. J Am Acad Dermatol. 2017 Aug;77(2):261-7. doi: 10.1016/j.jaad.2017.02.030.Elman SA, Joyce C, Nyberg F, et al. Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise. J Am Acad Dermatol. 2017 Aug;77(2):261-7. doi: 10.1016/j.jaad.2017.02.030.Requena L, Sanchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001 Sep;45(3):325-61; quiz 362-4. doi: 10.1067/mjd.2001.114735.Requena L, Sanchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001 Sep;45(3):325-61; quiz 362-4. doi: 10.1067/mjd.2001.114735.Grossberg E, Scherschun L, Fivenson DP. Lupus profundus: not a benign disease. Lupus. 2001;10(7):514-6. doi: 10.1191/096120301678416105.Grossberg E, Scherschun L, Fivenson DP. Lupus profundus: not a benign disease. Lupus. 2001;10(7):514-6. doi: 10.1191/096120301678416105.Castrillуn MA, Murrell DF. Lupus profundus limited to a site of trauma: Case report and review of the literature. Int J Womens Dermatol. 2017 May 5;3(2):117-20. doi: 10.1016/j.ijwd.2017.03.002.Castrillуn MA, Murrell DF. Lupus profundus limited to a site of trauma: Case report and review of the literature. Int J Womens Dermatol. 2017 May 5;3(2):117-20. doi: 10.1016/j.ijwd.2017.03.002.Fraga J, Garcia-Diez A. Lupus erythematosus panniculitis. Dermatol Clin. 2008 Oct; 26(4):453-63, vi. doi: 10.1016/j.det.2008.06.002.Fraga J, Garcia-Diez A. Lupus erythematosus panniculitis. Dermatol Clin. 2008 Oct; 26(4):453-63, vi. doi: 10.1016/j.det.2008.06.002.Ribero S, Sciascia S, Borradori L, Lipsker D. The Cutaneous Spectrum of Lupus Erythematosus. Clin Rev Allergy Immunol. 2017 Dec;53(3):291-305. doi: 10.1007/s12016-017-8627-2.Ribero S, Sciascia S, Borradori L, Lipsker D. The Cutaneous Spectrum of Lupus Erythematosus. Clin Rev Allergy Immunol. 2017 Dec;53(3):291-305. doi: 10.1007/s12016-017-8627-2.Fraga J, Garcia-Diez A. Lupus erythematosus panniculitis. Dermatol Clin. 2008 Oct; 26(4):453-63, vi. doi: 10.1016/j.det.2008.06.002.Fraga J, Garcia-Diez A. Lupus erythematosus panniculitis. Dermatol Clin. 2008 Oct; 26(4):453-63, vi. doi: 10.1016/j.det.2008.06.002.Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10(6): 365-81. doi: 10.2165/11310780-000000000-00000.Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10(6): 365-81. doi: 10.2165/11310780-000000000-00000.Zhao YK, Wang F, Chen WN, et al. Lupus Panniculitis as an Initial Manifestation of Systemic Lupus Erythematosus: A Case Report. Medicine (Baltimore). 2016 Apr; 95(16):e3429. doi: 10.1097/MD.0000000000003429.Zhao YK, Wang F, Chen WN, et al. Lupus Panniculitis as an Initial Manifestation of Systemic Lupus Erythematosus: A Case Report. Medicine (Baltimore). 2016 Apr; 95(16):e3429. doi: 10.1097/MD.0000000000003429.Siddiqui A, Bhatti HA, Ashfaq J. Lupus Profundus: A Case Report from Pakistan. Cureus. 2018 May 28;10(5):e2697. doi: 10.7759/cureus.2697.Siddiqui A, Bhatti HA, Ashfaq J. Lupus Profundus: A Case Report from Pakistan. Cureus. 2018 May 28;10(5):e2697. doi: 10.7759/cureus.2697.Patel S, Hardo F. Chilblain lupus erythematosus. BMJ Case Rep. 2013 Nov 27;2013: bcr2013201165. doi: 10.1136/bcr-2013-201165.Patel S, Hardo F. Chilblain lupus erythematosus. BMJ Case Rep. 2013 Nov 27;2013: bcr2013201165. doi: 10.1136/bcr-2013-201165.Su WP, Perniciaro C, Rogers RS 3rd, White JW Jr. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis. 1994 Dec;54(6):395-9.Su WP, Perniciaro C, Rogers RS 3rd, White JW Jr. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis. 1994 Dec;54(6):395-9.Bansal S, Goel A. Chilblain lupus erythematosus in an adolescent girl. Indian Dermatol Online J. 2014 Nov;5(Suppl 1):S30-2. doi: 10.4103/2229-5178.144522.Bansal S, Goel A. Chilblain lupus erythematosus in an adolescent girl. Indian Dermatol Online J. 2014 Nov;5(Suppl 1):S30-2. doi: 10.4103/2229-5178.144522.Weber F, Schmuth M, Fritsch P, Sepp N. Lymphocytic infiltration of the skin is a photosensitive variant of lupus erythematosus: evidence by phototesting. Br J Dermatol. 2001 Feb;144(2):292-6. doi: 10.1046/j.1365-2133.2001.04017.x.Weber F, Schmuth M, Fritsch P, Sepp N. Lymphocytic infiltration of the skin is a photosensitive variant of lupus erythematosus: evidence by phototesting. Br J Dermatol. 2001 Feb;144(2):292-6. doi: 10.1046/j.1365-2133.2001.04017.x.Patsinakidis N, Kautz O, Gibbs BF, Raap U. Lupus erythematosus tumidus: clinical perspectives. Clin Cosmet Investig Dermatol. 2019 Oct 1;12:707-19. doi: 10.2147/CCID.S166723.Patsinakidis N, Kautz O, Gibbs BF, Raap U. Lupus erythematosus tumidus: clinical perspectives. Clin Cosmet Investig Dermatol. 2019 Oct 1;12:707-19. doi: 10.2147/CCID.S166723.Patsinakidis N, Gambichler T, Lahner N, et al. Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus. J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2097-104. doi: 10.1111/jdv.13769.Patsinakidis N, Gambichler T, Lahner N, et al. Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus. J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2097-104. doi: 10.1111/jdv.13769.Schmitt V, Meuth AM, Amler S, et al. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus. Br J Dermatol. 2010 Jan;162(1):64-73. doi: 10.1111/j.1365-2133.2009.09401.x.Schmitt V, Meuth AM, Amler S, et al. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus. Br J Dermatol. 2010 Jan;162(1):64-73. doi: 10.1111/j.1365-2133.2009.09401.x.Hussein MR, Aboulhagag NM, Atta HS, Atta SM. Evaluation of the profile of the immune cell infiltrate in lichen planus, discoid lupus erythematosus, and chronic dermatitis. Pathology. 2008 Dec;40(7):682-93. doi: 10.1080/00313020802320739.Hussein MR, Aboulhagag NM, Atta HS, Atta SM. Evaluation of the profile of the immune cell infiltrate in lichen planus, discoid lupus erythematosus, and chronic dermatitis. Pathology. 2008 Dec;40(7):682-93. doi: 10.1080/00313020802320739.Jicha KI, Wang DM, Miedema JR, Diaz LA. Cutaneous lupus erythematosus/lichen planus overlap syndrome. JAAD Case Rep. 2021 Oct 5;17:130-151. doi: 10.1016/j.jdcr.2021.09.031.Jicha KI, Wang DM, Miedema JR, Diaz LA. Cutaneous lupus erythematosus/lichen planus overlap syndrome. JAAD Case Rep. 2021 Oct 5;17:130-151. doi: 10.1016/j.jdcr.2021.09.031.

The authors declare that there are no conflicts of interest present.